Ropes & Gray represented Ionis Pharmaceuticals in the deal. Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has entered into a license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka)...
Ionis Pharmaceuticals’ Licensing Agreement with Otsuka
Ionis Pharmaceuticals’ $575 Million Convertible Senior Notes Offering
Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...